First In-Man Experience Exceeds Expectations, Cited as “Game Changer” for Below-the-Knee Procedures CAMBRIDGE, Mass.--(BUSINESS WIRE)--Summa Therapeutics, LLC announced today that the first-in-man ...
Angioplasty with sirolimus-coated balloons, as compared with uncoated balloons, reduced limb amputation and other adverse ...
New Peripheral Angioplasty Balloon Targets Challenging Lesions in Lower-Extremity, Including Below-the-Knee, Arteries Associated with Critical Limb Ischemia MINNEAPOLIS. -- Aligned with its commitment ...
MOUNTAIN VIEW, Calif., Jan. 18, 2011 /PRNewswire/ -- Hotspur Technologies, Inc. announced today that Dr. Greg Sampognaro, Interventional Cardiologist at P & S Surgical Hospital in Monroe, Louisiana, ...
SINGAPORE, Nov. 11, 2022 /PRNewswire/ -- Genesis MedTech Group announced today that the Food and Drug Administration (FDA) has approved the Chocolate Touch® Drug-coated Balloon PTA Catheter, developed ...
Ultra-low profile, highly deliverable balloon dilatation catheter offers physicians exceptional performance in peripheral angioplasty procedures NATICK, Mass., Boston Scientific Corporation has ...
Please provide your email address to receive an email when new articles are posted on . IVUS-guided angioplasty for peripheral artery disease improved procedural outcomes vs. an angiography-guided ...
ILLUMENATE FIH Study Delivers Promising Safety and Effectiveness Data for Treatment of Peripheral Arterial Disease PARIS--Covidien, a leading global provider of healthcare products, announced the ...
SINGAPORE, Aug. 31, 2020 /PRNewswire/ -- Genesis MedTech International has completed the acquisition of the Chocolate Touch ® drug-coated balloon (DCB), a drug-device technology asset from TriReme ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results